[1]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2020/180768,2020,A1Locationinpatent:Paragraph00298;00343
[1]CurrentPatentAssignee:C4THERAPEUTICSINC;BIOGENIDECINC.-WO2022/235945,2022,A1Locationinpatent:Page/Pagecolumn93-94
888720-29-4
1160995-23-2
1403767-33-8
910444-80-3 | 2-Naphthalen-1-yl-piperazine | AA00GRZ5 | MFCD06797784
866156-93-6 | 4-(Pyrazin-2-yloxy)benzaldehyde | AA00GS69 | MFCD02667635
93951-70-3 | HEXACHLORO-1,3-BUTADIENE (13C4) | AA00GSHF | MFCD00144437
876716-04-0 | [(1-Isopropylpiperidin-4-yl)methyl]methylamine | AA00GSOB | MFCD07643229
913835-57-1 | N-(2-Hydroxyethyl) 3-boronobenzenesulfonamide | AA00GSW0 | MFCD08436067
933030-60-5 | (E)-C-HDMAPP (ammonium salt) | AA00GT7H | MFCD18428007
935701-04-5 | 3-(Acetoxymethyl)phenylboronic acid | AA00GTBD | MFCD11053792
939983-61-6 | (Piperazin-1-yl)-acetamide 2 hcl 1/2 h2o | AA00GTI8 | MFCD09832396
915923-39-6 | 5-(2,5-Dimethylphenyl)-3-hydrazinyl-1,2,4-triazine | AA00GTNB | MFCD08691589
88319-45-3 | Z-Beta-tbu-ala-oh dcha | AA00GTR5 | MFCD02259500